z-logo
open-access-imgOpen Access
Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings
Author(s) -
Hyungjin Myra Kim,
Lauren B. Gerlach,
Matheos Yosef,
Claire Stano,
Deirdre A. Conroy,
Marcia Valenstein,
P. Pfeiffer,
Anne Sales,
Kara Zivin
Publication year - 2018
Publication title -
journal of clinical sleep medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 92
eISSN - 1550-9397
pISSN - 1550-9389
DOI - 10.5664/jcsm.7210
Subject(s) - veterans affairs , health care , medicine , library science , management , gerontology , family medicine , political science , law , computer science , economics
Sedative hypnotic medications are routinely prescribed for insomnia treatment, but have been associated with significant risks of morning-after impairment. We evaluated responsiveness in the Veterans Health Administration (VHA) facilities to two drug safety warnings recommending against high-dose zolpidem use-a 2007 Veterans Administration Pharmacy Benefits Management Service warning and a 2013 Food and Drug Administration (FDA) warning.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom